High P/S ratio for Shanghai Allist Pharmaceuticals could dis...
High P/S ratio for Shanghai Allist Pharmaceuticals could discourage investors if revenue growth slows. Analysts question sustainability of current P/S ratio, suggesting share price may struggle unless significant industry outperformance.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000150142cf4370b4.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment